TNF and rheumatoid arthritis: Our results demonstrate very low or undetectable levels of IL6 mRNA from peripheral blood cells of stable RA patients treated with DMARD therapy and in stable RA patients treated with combination DMARD and anti-TNF-α therapy, suggesting significant attenuation of the proinflammatory cytokine cascade that contributes to the progression of RA.